VCYT Q1 2018 Earnings — Veracyte, Inc. Revenue & Financial Results | Market Cap Arena

VCYTVeracyte, Inc.

$3B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$20M+22.0% YoY

Gross Profit

$12M60.7% margin

Operating Income

-$9M-44.7% margin

Net Income

-$9M-45.8% margin

EPS (Diluted)

$-0.27

QoQ Revenue Growth

+2.3%

Cash Flow

Operating Cash Flow

-$7M

Free Cash Flow

-$8M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$71M

Total Liabilities

$41M

Stockholders' Equity

$30M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$16M	+22.0%
Gross Profit	$12M	$10M	+20.1%
Operating Income	-$9M	-$8M	-19.1%
Net Income	-$9M	-$8M	-11.7%